TCR² Therapeutics to Present at SVB Securities Global Biopharma Conference 2023

February 8, 2023

https://www.globenewswire.com/news-release/2023/02/08/2603758/0/en/TCR-Therapeutics-to-Present-at-SVB-Securities-Global-Biopharma-Conference-2023.html

CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — TCR² Therapeutics Inc. (Nasdaq:TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from solid tumors, today announced that management will present a company update at the SVB Securities Global Biopharma Conference (virtual) on Tuesday, February 14, 2023 at 1:00 PM ET.

Read more at globenewswire.com

Related news for (TCRR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.